Identification and referral to improve safety of women experiencing domestic violence (IRIS): Protocol for a pragmatic cluster randomised controlled trial by Gregory, Alison et al.
Gregory, A., Ramsay, J., Agnew-Davies, R., Baird, K., Devine, A.,
Dunne, D., Eldridge, S., Howell, A., Johnson, M., Rutterford, C.,
Sharp, D. and Feder, G. and Bristol University (2010) Identification
and referral to improve safety of women experiencing domestic vio-
lence (IRIS): Protocol for a pragmatic cluster randomised controlled
trial. BMC Public Health, 10 (54). ISSN 1471-2458 Available from:
http://eprints.uwe.ac.uk/7957
We recommend you cite the published version.
The publisher’s URL is:
http://dx.doi.org/10.1186/1471-2458-10-54
Refereed: Yes
(no note)
Disclaimer
UWE has obtained warranties from all depositors as to their title in the material
deposited and as to their right to deposit such material.
UWE makes no representation or warranties of commercial utility, title, or fit-
ness for a particular purpose or any other warranty, express or implied in respect
of any material deposited.
UWE makes no representation that the use of the materials will not infringe
any patent, copyright, trademark or other property or proprietary rights.
UWE accepts no liability for any infringement of intellectual property rights
in any material deposited but will remove such material from public view pend-
ing investigation in the event of an allegation of any such infringement.
PLEASE SCROLL DOWN FOR TEXT.
STUDY PROTOCOL Open Access
Primary care Identification and Referral to
Improve Safety of women experiencing domestic
violence (IRIS): protocol for a pragmatic cluster
randomised controlled trial
Alison Gregory1, Jean Ramsay2, Roxane Agnew-Davies3, Kathleen Baird4, Angela Devine2, Danielle Dunne2,
Sandra Eldridge2, Annie Howell5, Medina Johnson6, Clare Rutterford2, Debbie Sharp1, Gene Feder1*
Abstract
Background: Domestic violence, which may be psychological, physical, sexual, financial or emotional, is a major
public health problem due to the long-term health consequences for women who have experienced it and for
their children who witness it. In populations of women attending general practice, the prevalence of physical or
sexual abuse in the past year from a partner or ex-partner ranges from 6 to 23%, and lifetime prevalence from 21
to 55%. Domestic violence is particularly important in general practice because women have many contacts with
primary care clinicians and because women experiencing abuse identify doctors and nurses as professionals from
whom they would like to get support. Yet health professionals rarely ask about domestic violence and have little
or no training in how to respond to disclosure of abuse.
Methods/Design: This protocol describes IRIS, a pragmatic cluster randomised controlled trial with the general
practice as unit of randomisation. Our trial tests the effectiveness and cost-effectiveness of a training and support
programme targeted at general practice teams. The primary outcome is referral of women to specialist domestic
violence agencies. Forty-eight practices in two UK cities (Bristol and London) are randomly allocated, using
minimisation, into intervention and control groups. The intervention, based on an adult learning model in an
educational outreach framework, has been designed to address barriers to asking women about domestic violence
and to encourage appropriate responses to disclosure and referral to specialist domestic violence agencies.
Multidisciplinary training sessions are held with clinicians and administrative staff in each of the intervention
practices, with periodic feedback of identification and referral data to practice teams. Intervention practices have a
prompt to ask about abuse integrated in the electronic medical record system. Other components of the
intervention include an IRIS champion in each practice and a direct referral pathway to a named domestic violence
advocate.
Discussion: This is the first European randomised controlled trial of an intervention to improve the health care
response to domestic violence. The findings will have the potential to inform training and service provision.
Trial registration: ISRCTN74012786
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Background
The scale of the problem
Domestic violence is threatening behaviour, violence or
abuse (psychological, physical, sexual, financial or emo-
tional) between adults who are in the same family or
who are (or have been) intimate partners. The preva-
lence of physical and sexual violence varies internation-
ally from 15 to 71% [1]. The 2001 British Crime Survey
reported that 20% of women in England and Wales
were physically assaulted by a current or former partner
at some time in their lives. When threats, financial
abuse and emotional abuse are included, this increased
to 25% of women [2]. The prevalence of domestic vio-
lence among women seeking healthcare is higher than
the general population. In populations of women attend-
ing general practice, the prevalence of physical or sexual
abuse in the past year from a partner or ex-partner
ranges from 6 to 23%, and lifetime prevalence from 21
to 55% [3]. The two fold variation reflects different mea-
sures or abuse, as well as national and regional differ-
ences. In a questionnaire survey of 1035 women
attending east London general practices the prevalence
of physical abuse in the past year from a partner or ex-
partner ranges was 17% and lifetime prevalence 40% [4].
The 2008 costs of domestic violence to the UK econ-
omy, including services, loss of economic output, and
human and emotional costs is £16 billion annually [5].
Health consequences
Domestic violence damages health. Survivors suffer
many chronic health problems including: gynaecological
problems [6], chronic pain and neurological symptoms
[7], gastrointestinal disorders [8,9], and self-reported
cardiovascular conditions [10]. Domestic violence may
start or escalate during pregnancy [11,12] with the most
serious outcomes being the death of the mother [13] or
the foetus [14,15] and a consistent association with low
birth weight, taking into account parity, age and socioe-
conomic status [16,17]. There is overwhelming evidence
for the impact of domestic violence on mental health
[2], which can last long after the violence has ceased.
The most prevalent mental health sequelae of domestic
violence are depression and post-traumatic stress disor-
der (PTSD), with parallels to the trauma of being taken
hostage and subjected to torture [16,18-23]. Coid and
colleagues’ study of women with a lifetime experience of
domestic violence attending general practices in London,
found odds ratios greater than three for depression,
anxiety and PTSD, and greater than two for suicide
attempt, use of illegal drugs and alcohol abuse [24].
Women experiencing domestic violence present fre-
quently to health services and require wide-ranging
medical care [25,26]. Witnessing of domestic violence by
children results in developmental problems and long
term mental health, educational and social sequelae
[27-29].
Current health care response is inadequate
Healthcare may be a survivor’s first or only point of
contact with professionals [30] and abused women are
more likely to be in touch with health services than any
other agency [31]. Eighty percent of women in a violent
relationship seek help from health services at least once
[32] and women suffering from the effects of domestic
violence typically make 7-8 visits to health professionals,
either on their own or on someone else’s behalf, before
disclosure of abuse [33].
The magnitude of the health consequences of domes-
tic violence contrasts starkly with its virtual invisibility
within primary care; in one general practice based ques-
tionnaire study only 15% of women with a history of
domestic violence had any reference to violence in their
medical record [34]. Specialist domestic violence agen-
cies receive few referrals from health care services. If
women disclose domestic violence to a clinician,
whether in a primary care or specialist setting, there is
evidence of an inappropriate, poor quality response [35].
Doctors and nurses in general are largely unaware of
appropriate interventions and have seldom received
effective or, indeed, any training [36]. Yet the issue of
domestic violence is particularly important in this con-
text because of the extensive contact between women
and primary care clinicians (90% consult in 5 years), and
because abused women themselves identify primary care
clinicians as the people from whom they would seek
support [37].
Evidence for effectiveness of system level interventions
and specialist domestic violence advocacy
There is evidence that system level training and organi-
sational change can increase the disclosure of domestic
violence to healthcare professionals, although this con-
clusion is largely based on non-randomised North
American studies [38] and is not consistently found in
randomised trials [39]. There is even less evidence that
clinician training or organisational change results in bet-
ter care or referral to specialist domestic violence ser-
vices [38], and the only trial to date measuring women
centred outcomes (reoccurrence of violence or quality
of life) of a system level screening intervention found no
significant differences between intervention and control
arms [40].
Referral to domestic violence services that provide
specialist advocacy is a proxy outcome for interventions
aiming to improve the health service response to
domestic violence. In the context of domestic violence
services, advocacy is a term that varies within and
between countries, depending on institutional settings
and historical developments of the role of advocates.
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Advocates engage with individual clients who are being
abused, aiming to empower them and linking them to
community services. In some health settings they may
also have a role in bringing about system change, cata-
lysing increased recognition by clinicians of women
experiencing abuse. Core activities of advocacy include:
provision of legal, housing and financial advice, facilitat-
ing access to and use of community resources, such as
refuges (shelters, safe houses), emergency housing, and
provision of safety planning advice. Advocates can also
provide ongoing support and informal counseling. In a
2009 Cochrane review confined to randomized con-
trolled trials of domestic violence advocacy, Ramsay and
colleagues concluded that there was equivocal evidence
that advocacy for women recruited in domestic violence
shelters (refuges) had a beneficial effect on their physical
and psychosocial well-being, and were unable to draw
any conclusions for women receiving advocacy in or
referred from health care settings [41]. In a broader sys-
tematic review which included all controlled studies of
domestic violence advocacy, Feder and colleagues
reported that most showed improvement in some
women-centred outcomes. In particular, for women who
have actively sought help from professional services,
advocacy can reduce abuse, increase social support and
quality of life, and lead to increased usage of safety
behaviours and accessing of community resources [42].
Five of the eleven studies had participants recruited
within health care settings [43-49].
In summary, domestic violence is a major public
health problem with a poor response from health care
services. There is insufficient evidence for system level
interventions to improve this response and there is a
need to rigorously test such interventions.
This paper describes the protocol of a cluster rando-
mised controlled trial of a domestic violence training
and support programme targeted at general practice
teams, comparing the outcomes for practices that
receive the intervention to those that do not.
Methods/Design
Primary Objective
• To determine the effectiveness of an intervention
delivered in general practice, designed to improve
recording and management of domestic violence in
primary care, compared with usual practice in terms
of the rate of referral to a specialist domestic vio-
lence agency providing advocacy.
Secondary Objectives
• To determine the effectiveness of an intervention
delivered at the general practice level, designed to
improve recording and management of domestic vio-
lence in primary care, compared to usual practice in
terms of the rate of domestic violence disclosure in
relation to the number of women aged 16 or older
registered in the practice.
• To estimate the cost effectiveness of the
intervention.
• To determine whether individual physician atti-
tudes, knowledge and behaviour in relation to
domestic violence change after the intervention.
Practice recruitment
General practices in two primary care trusts in the
south west of England (Bristol) and east London (Hack-
ney) are eligible for participation if they have EMIS LV,
EMIS PCS or iSoft Synergy electronic medical record
systems. These systems allow the use of clinician
prompts and templates within the medical record and
were the dominant systems in both areas (>90%).
We have obtained lists of practices in two primary
care trusts in the south west of England (Bristol) and
east London (City and Hackney) and stratified them by
practice characteristics: number of whole time equiva-
lent doctors, training status and presence of a practice
counselor. All practices on the lists with the relevant
record systems were considered eligible for the trial
except for two in which investigators were practicing. A
stratified random sample of the general practices in
each site was generated from random number tables
and those practices were then contacted in rank order.
General practices received a postal invitation to partici-
pate, including details of the study and a copy of an edi-
torial from a general practice journal highlighting
domestic violence as a central primary care issue [50].
The invitation was followed up within a fortnight by tel-
ephone contact with one of the general practitioners
(GF in London and DS in Bristol) to discuss possible
participation. Practices where initial interest in the study
was expressed were posted or e-mailed a further infor-
mation sheet, and given time to consider participation
in the trial. Practices wishing to have further details or
clarification were offered a practice visit to explain the
study in more detail. Implicit consent from individual
clinicians within recruited practices was assumed from
their subsequent attendance at training sessions and
their completion of study questionnaires.
Study design and practice allocation
As the intervention was targeted at the practice teams
(clinicians and reception staff), the trial is cluster rando-
mised with the practice as unit of analysis. The 48 prac-
tices recruited in both Hackney and Bristol were
allocated (by JR for Hackney practices and DD for Bris-
tol practices) to intervention and control arms of the
trial with a computer minimisation programme, includ-
ing a random component (Minim Version 1.3). Alloca-
tion was determined by the programme and the process
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was concealed from the person entering practice mini-
misation variables. The variables were the percentage of
female doctors in the practice (whole time equivalents),
postgraduate training status, the number of patients
registered with the practice, and the percentage of the
practice population on low incomes.
Intervention
The training and support intervention within an educa-
tional outreach framework [51], has a theoretical basis
in adult learning theory and peer influence [52]. It
focuses on addressing the barriers to asking women
patients about abuse and responding appropriately,
which includes offering referral to a specialist domestic
violence agency that provided advocacy. The primary
intervention consisted of two 2-hour multidisciplinary
training sessions, scheduled at lunchtime on practice
premises, targeted at the clinical team: general practi-
tioners, directly employed practice staff (practice nurses
and counselors), and those employed by primary care
trusts (midwives, health visitors, district nurses) who
have contact with patients registered in the practice.
The training sessions were designed to address the
expressed and tacit barriers to improving the response
of clinicians to women experiencing abuse through
improved identification, support and referral to specialist
agencies. These sessions incorporated case studies and
role play in relation to asking about violence and
responding appropriately. They were delivered by an
advocate educator based in one of the two collaborating
specialist agencies: Nia project in London http://www.
niaproject.info/ and Next Link in Bristol http://www.
nextlinkhousing.co.uk/, a clinical psychologist specializ-
ing in domestic violence and an academic general prac-
titioner. The advocate educator was central to the
intervention, combining a training and support role to
the practices with provision of advocacy to women
referred from the practices. The training sessions were
followed by periodic contact with the practice in clinical
meetings, feeding back anonymised practice data on dis-
closure and referral to the advocacy service, and reinfor-
cing guidance on good practice with regards to
domestic violence, as well as ad hoc telephone conversa-
tions with clinicians about referrals or advice. One hour
training sessions with administrative staff focused on
issues of confidentiality and safety for patients experien-
cing abuse and introduced the IRIS information materi-
als signposting domestic violence agencies. Ongoing
support to clinicians and reception staff in the practices
was provided by the named domestic violence advocate
educator, with the aim of consolidating the initial
training
Intervention practices also were asked to identify a
“champion” for the project; with the agreement of the
practice, a member of staff from any of the clinical
disciplines was invited to attend an additional two days
training about domestic violence and to integrate this
into the work of the practice.
Other components of the intervention include: a pop-
up template linked to diagnoses (such as depression,
anxiety, irritable bowel syndrome, pelvic pain and
assault) which acts as a prompt to remind clinicians to
ask questions about domestic violence and to record
this in the electronic medical record, an explicit referral
pathway to the named advocate in the Nia project and
Next Link and publicity materials about domestic vio-
lence visible in the practices (waiting rooms and
women’s toilets). The template in the electronic medical
record is based on HARK, four questions which have
been validated for the identification of intimate partner
violence in UK general practice [51].
Control practices are offered the training sessions
once the follow-up period for the intervenrm of the trial
is complete.
Primary Outcome
Our primary outcome is the rate of referral to advocacy
and/or specialist domestic violence agencies for one year
following the educational sessions in intervention prac-
tices (measured for each practice in the intervention and
control arms). A woman aged 16 or over is counted as a
referral within the practice if her general practitioner
records referral information. The denominator is the
number of women aged 16 or over within the practice.
Secondary Outcomes
Domestic violence disclosure rate for one year following
the educational sessions in intervention practices: this is
measured for each practice (intervention and control)
from searches of the practice database for domestic vio-
lence codes in the electronic medical record. The
denominator is the number of women aged 16 or above
within each practice.
Resource use and associated costs of the intervention
are collected for estimation of the IRIS programme’s
cost-effectiveness.
Physician Readiness to Manage Partner Violence Sur-
vey (PREMIS) [53]: this is completed by health profes-
sionals within each intervention and control practice at
two time points (baseline and twelve months post inter-
vention). We compare sum scores for perceived pre-
paration, perceived knowledge, actual knowledge,
opinions and self-reported practices.
Data collection
Data are collected by research associates from the elec-
tronic medical records in each intervention practice
twelve months after the second training session. This
comprises identification and referral to domestic vio-
lence advocacy of women who have experienced or are
experiencing domestic violence. We are searching over
two time periods: (i) the twelve month period preceding
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the intervention, and (ii) the twelve month period after
the second training session. Use of the trial template
and/or domestic violence codes is identified by a series
of computer searches, followed by examination of any
eligible patient’s electronic record that contains these
codes, to determine identification or referral to any
agency providing domestic violence advocacy. The same
data are collected from the control group practices (the
only exception being that identification data based on
the use of the trial template codes will not be available).
At the time of follow-up data collection for each inter-
vention practice, data are collected from a control prac-
tice recruited at least 12 months prior to the data
collection time point with similar practice size and
training practice status to ensure comparability in the
timing of data collection from similar practices.
Whether a record of identification or referral is pre-
sent in a record or not, is determined using a detailed
flowchart (available from authors) to reduce subjectivity.
If the researchers extracting data from the medical
record are uncertain about whether an identification or
a referral was made or not, this will be referred to an
independent outcomes panel, blinded to the arm of the
trial and identity of the practice the case came from, for
a decision. The panel members consist of two general
practitioners (one with extensive domestic violence
research experience) and a trial methodologist. Direct
extracts from the medical record are presented to the
table and decisions are made by majority voting if there
is no unanimity. Validity of referral data collection will
be assessed by an independent researcher searching and
extracting from the records of four randomly selected
practices in each of the two sites.
Some women may self-refer to various agencies for
support or be referred by other professionals. As these
referrals may be affected by our intervention (either
negatively or positively), other sources of referral data
will also be collected and sensitivity analyses conducted:
(i) self-referral or referral from a non-general practice
source recorded in advocacy service logs, (ii) clinician
referral recorded in the advocate educators’ records, (iii)
referral to other domestic violence agencies. After the
primary analysis based on referrals in the general prac-
tice record, we will conduct sensitivity analyses, combin-
ing these referrals sequentially with referrals in (i), (ii),
(iii) and finally with all referral sources combined.
Cost data for the intervention are directly recorded:
salaries and management costs of advocate educators,
materials (posters and cards), practice payments for
training sessions and travel costs. Data on domestic vio-
lence costs are based on secondary sources [5].
The ‘Physician Readiness to Manage Partner Violence
Survey’ (PREMIS) questionnaire is completed by GPs
and practice nurses in intervention and control practices
at baseline, and again concurrent with outcome data
collection one year later.
Masking (blinding)
Due to the nature of the intervention, patients and
practice staff cannot be blinded to allocation status,
although patients are given no explicit information
about the intervention. Research associates collecting
outcome data could not be blinded to allocation status,
but we have used a detailed flowchart for extraction to
minimize this, plus referral to a panel for arbitration
over difficult cases. We are also validating a sample of
our data collection using a blinded researcher. All ana-
lyses will be conducted blind to treatment allocation.
Sample size
With 24 intervention and 24 control practices, assum-
ing a disclosure rate of 1% in control practices (a con-
servative estimate based on our survey of 12 Hackney
practices [54] and an intra-cluster correlation coeffi-
cient of 0.03, we will be able to detect an increase of
5.2% in the disclosure rate with a power of 80% at a
significance level of 0.05. This calculation assumes that
there are on average 1600 women in the relevant age
group in each practice, and also takes account of varia-
tion in cluster size. With this number of practices we
will also be able to reliably detect a three-fold differ-
ence between intervention and control practices in the
referral of women disclosing abuse to domestic vio-
lence advocacy services.
Analysis
Analyses of referral and identification will be by inten-
tion to treat with a Poisson regression model. Our inde-
pendent variable is the number of referrals/
identifications for each cluster. The number of women
aged 16 or older will be included as the exposure and
practice will be included as a random effect. The analy-
sis will be adjusted for minimization factors. Addition-
ally the analysis will be adjusted for the practice baseline
rate if considered to improve the precision of our treat-
ment estimate and not adversely affecting the fit of the
model.
Directly collected cost data for the intervention will be
combined with service costs and costs of domestic vio-
lence in relation to imputed benefits of advocacy referral
in a Markov model to calculate cost effectiveness in
terms of cost per quality adjusted life years. We have
used this approach in a pilot study for this trial [55].
Before-and-after analyses of scores for each of the
three sections of the PREMIS questionnaire (knowledge,
opinion, practice) will be carried out using descriptive
statistics and multivariable models (including respon-
dent characteristics) to test for the effect of the
intervention.
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Discussion
This is the first European randomised controlled trial of
an intervention to improve the health care response to
domestic violence. The intervention is a collaboration
between primary health care services and third sector
agencies specialising in domestic violence, combining
educational outreach training sessions in general prac-
tices with a referral pathway to a named advocate-educa-
tor who also was part of the team delivering the training.
Additional components of the intervention included a
prompt to ask about domestic violence embedded in the
medical record and continuing audit and feedback on
disclosure and referral data. The primary outcome mea-
sure- referral to domestic violence advocacy - is an inter-
mediate outcome, on a causal pathway towards reduced
violence, and improved quality of life and mental health
for women who are referred. We will put our results into
a model that extrapolates to those outcomes, which will
estimate the cost-effectiveness of the intervention. As
health care services in the UK and internationally are
moving to address domestic violence [56], particularly
through training of clinicians, our findings - based on a
pragmatic trial - will have the potential to influence
health service policy. If they are positive, then the IRIS
model could be implemented within primary care. If they
are negative, then other interventions to improve identifi-
cation and referral of women experiencing domestic vio-
lence need to be developed.
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